Skip to main navigation Skip to search Skip to main content

Lipopolysaccharide prevents valproic acid-induced apoptosis via activation of nuclear factor-κB and inhibition of p53 activation

  • Bilegtsaikhan Tsolmongyn
  • , Naoki Koide
  • , Erdenezaya Odkhuu
  • , Abedul Haque
  • , Yoshikazu Naiki
  • , Takayuki Komatsu
  • , Tomoaki Yoshida
  • , Takashi Yokochi

    Research output: Contribution to journal › Article › peer-review

    Abstract

    The effect of lipopolysaccharide (LPS) on valproic acid (VPA)-induced cell death was examined by using mouse RAW 264.7 macrophage cells. LPS inhibited the activation of caspase 3 and poly (ADP-ribose) polymerase and prevented VPA-induced apoptosis. LPS inhibited VPA-induced p53 activation and pifithrin-α as a p53 inhibitor as well as LPS prevented VPA-induced apoptosis. LPS abolished the increase of Bax/Bcl-2 ratio, which is a critical indicator of p53-mediated mitochondrial damage, in response to VPA. The nuclear factor (NF)-κB inhibitors, Bay 11-7082 and parthenolide, abolished the preventive action of LPS on VPA-induced apoptosis. A series of toll-like receptor ligands, Pam3CSK4, poly I:C, and CpG DNA as well as LPS prevented VPA-induced apoptosis. Taken together, LPS was suggested to prevent VPA-induced apoptosis via activation of anti-apoptotic NF-κB and inhibition of pro-apoptotic p53 activation. The detailed inhibitory mechanism of VPA-induced apoptosis by LPS is discussed.

    Original languageEnglish
    Pages (from-to)100-105
    Number of pages6
    JournalCellular Immunology
    Volume282
    Issue number2
    DOIs
    Publication statusPublished - 04-2013

    All Science Journal Classification (ASJC) codes

    • Immunology

    Fingerprint

    Dive into the research topics of 'Lipopolysaccharide prevents valproic acid-induced apoptosis via activation of nuclear factor-κB and inhibition of p53 activation'. Together they form a unique fingerprint.

    Cite this